DDuality Biotherapeutics, Inc. - B: directors' dealings · Hong Kong · HKEX
HKEX:duality-biotherapeutics-inc-bHKHK·HKEXMcap 19.9Bn€Healthcare
Explore the full insider trade history of Duality Biotherapeutics, Inc. - B, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Duality Biotherapeutics, Inc. - B has recorded 1 reports. Market capitalisation: €19.9bn. The latest transaction was filed on 1 April 2026 (Other). Among the most active insiders: Hua Haiqing. All data is free.
Financial data
FY ended December 2025 · cache
Analyst consensus
7 analysts369.21 €Target 435.31 €(+95%)506.87 €
Income statement
Revenue1.85 Bn€
Gross profit589.1 M€32% margin
Net income−2.59 Bn€-140.1% margin
Valuation
PER (forward)-38.1x
P/Book7.1x
Balance sheet & cash
Market cap19.92 Bn€
Total debt149.8 M€
Free Cash Flow180.9 M€
Debt / Equity6%
Profitability & ownership
ROE-1282.1%
ROA-9.6%
% insiders46.0%
% institutions41.9%
Last declaration on 1 April 2026